| Identification | Back Directory | [Name]
Imidazo[1,2-a]pyridine-2-carboxamide, N-[7-cyano-2,3-dihydro-1,1-dioxido-6-(trifluoromethyl)benzo[b]thien-3-yl]-N-[2-(dimethylamino)ethyl]-3-(4-fluoro-3-methylphenyl)-5-methoxy- | [CAS]
1446399-26-3 | [Synonyms]
Imidazo[1,2-a]pyridine-2-carboxamide, N-[7-cyano-2,3-dihydro-1,1-dioxido-6-(trifluoromethyl)benzo[b]thien-3-yl]-N-[2-(dimethylamino)ethyl]-3-(4-fluoro-3-methylphenyl)-5-methoxy- | [Molecular Formula]
C30H27F4N5O4S | [MOL File]
1446399-26-3.mol | [Molecular Weight]
629.63 |
| Hazard Information | Back Directory | [Description]
Cmpd-A is a time-dependent CENP-E inhibitor with potent antitumor activity. Cmpd-A inhibits the ATPase activity of the CENP-E motor domain, acting as a time-dependent inhibitor with an ATP-competitive-like behavior. Cmpd-A causes chromosome misalignment on the metaphase plate, leading to prolonged mitotic arrest. Treatment with Cmpd-A induces antiproliferation in multiple cancer cell lines. |
|
|